medigraphic.com
SPANISH

Revista Biomédica

Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 3

<< Back Next >>

Rev Biomed 2005; 16 (3)

Serum glycosaminoglycans from rheumatoid arthritis patients do not affect reactive oxygen species secretion by normal monocytes.

Bravo-Cuéllar A, Ramos-Remus C, Carranco-López A, Flores-Hernández G, Gómez-Contreras PC, Orbach-Arbouys S
Full text How to cite this article

Language: English
References: 24
Page: 175-180
PDF size: 58.42 Kb.


Key words:

glucosaminoglycan, rheumatoid arthritis patients, oxygen reactive species, monocytes.

ABSTRACT

Introduction. Several observations suggest that macrophages play an important role in the physiopathology of rheumatoid arthritis (RA). One of the most important features of RA is the serious cartilage destruction with consequent glycosaminoglycans (GAG) release. Here we studied whether GAG from RA patients can induce peripheral blood monocytes to secrete reactive oxygen species (ROS), thus being responsible for the inflammatory injury.
Patients and methods. 10 female healthy postgraduate student volunteers and 10 female patients with RA were included. GAG were isolated and purifified according to Merhraban and Volpi methods. Mononuclear cells from 15 mL of peripheral blood were obtained and monocytes were identified by neutral red coloration and phagocytosis and purified by adherence to plastic. Chemiluminescence (CL) was measured on a LKB-1250 Bioluminometer at 37°C. The cuvettes contained 5 x 105 monocytes from healthy donors resuspended in Hank´s solution without phenol red at 37°C, pH 7.4. Different GAG concentrations from either normal volunteers (5, 40, 80, and 160 μg/mL) or RA patients (5 and 80 μg/mL) were resuspended in Hank´s solution in a standard volume of 100 μL. To elicit CL emission 100 μL of a solution containing 4 mg/mL of opsonized zymosan were added and photoemission was measured every ten minutes during 60 minutes.
Results. The electrophoretic patterns of serum GAG obtained from normal volunteers and RA patients were comparable: in both cases chondroitin 4 sulfate and chondroitin 6 sulfate were identified. No chemiluminescent signal was emitted by monocytes in presence of luminal and GAG, suggesting that GAG are not able to elicit respiratory burst in those cells, neither via protein C kinase Ca++ influx nor via Fc receptors. CL emission by zymosan of peripheral monocytes was higher in presence of GAG from RA patients than that in presence of GAG from normal volunteers or without GAG (increase of 36%). However, the difference was not statistically significant.
Conclusion. Serum GAG from patients are not likely to play a role in the physiopathology of RA linked to the secretion of ROS by monocytes.


REFERENCES

  1. 1.- Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79: 147-57.

  2. 2.- Brostoff J, Sccaddiding GK, Male D, Rott MI. Clinical Immunology. Gower Medical Publishing. Philadelphia. 1991.

  3. 3.- Ralphs JR, Benjamin M. The joint capsule: structure, composition, aging and disease. J Anatomy 1994; 184: 503-9.

  4. 4.- Poole AR, Ionescu M, Swan A, Dieppe DA. Changes in cartilage metabolism in artritis are reflected by altered serun and synovial fluid levels of the cartilage proteoglycan agregan. Implications for pathogenesis. J Clin Inv. 1994; 94: 25-33.

  5. 5.- Wrenshall LE, Stevens RB, Cerra FB, Platt JL. Modulations of macrophage and B cell function by glycosaminoglycans. J Leukoc Biol 1999; 66: 391-400.

  6. 6.- Kitchens RL. Role of CD14 in cellular recognition of bacterial lipopolysaccharides, in CD14 in the Inflammatory Response, R.S. Jack (ED) Chemical Immunology, vol. 74, KARGER 2000, pp 61-82.

  7. 7.- Dziarzki R, Tapping RI, Tobias P. Binding of bacterial peptidoglycan to CD14. J Biol Chem 1998; 273: 8680-90.

  8. 8.- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315.

  9. 9.- Mehraban F, Finegan CK, Moskowitz RW. Serum Keratan Sulfate. Quantitative comparisons in inflammatory versus non inflammatory arthritis. Arthritis Rheum 1991; 34: 383-92.

  10. 10.- Volpi N. Electrophoresis separations of glycosaminoglycans on nitrocellulose membranes. Annal Biochem 1996; 240: 114-8.

  11. 11.- Bravo-Cuellar A, Scott Algara D, Metzger G, Orbach-Arbouys S. Enhanced activity of mouse peritoneal cell after aclacinomycin administration. Cancer Res 1987; 47: 3477-88.

  12. 12.- Bravo-Cuellar A, Homo-Delarche F, Cabannes J, Orbach-Arbouys S. Enhanced activity of murine peritoneal cell after aclacinomycin administration: Characteristics of the enhanced respiratory burst. Cancer Res 1988; 48: 3440-4.

  13. 13.- Panasyuc A, Frati E, Ribault D, Mitrovic D. Effect of reactive oxygen species on the biosíntesis and structure of newly synthesized GAG. Free Rad Biol & Med 1994; 16: 157-67.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Biomed. 2005;16